IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Lymphoma, T-Cell
Memorial Sloan Kettering Cancer Centermonoclonal_antibodyPhase 2Active
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 61/ 100
- Competitive Position
- 81/ 100
Competitive context
20 Active assets in the Lymphoma, T-Cell cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cytosin-Arabinosid St. Jude Children's Research Hospital | Phase 3 | BB |
Romidepsin Sichuan University | Phase 3 | BB |
Tucidinostat The First Affiliated Hospital of Xiamen University | Phase 3 | BB |
Pralatrexate Fred Hutchinson Cancer Center | Phase 3 | BB |
ETOPOSIDE Yale University | Phase 3 | BB |
View all 34 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →